In vivo evolution of antimicrobial resistance in a series of Staphylococcus aureus patient isolates: The entire picture or a cautionary tale?

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 2, 2014, Pages 363-367

  Van Hal, Sebastiaan J ^a,b   Steen, Jason A ^c   Espedido, Björn A ^a,d   Grimmond, Sean M ^c   Cooper, Matthew A ^c   Holden, Matthew T G ^e   Bentley, Stephen D ^e   Gosbell, Iain B ^a,b,d   Jensen, Slade O ^a,d  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b South Western Sydney Clinical School   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d INGHAM INSTITUTE FOR APPLIED MEDICAL RESEARCH   (Australia)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Diagnostics; Genomics; MRSA; Sub populations

Indexed keywords

BACTERIAL DNA; DAPTOMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; BLOOD SAMPLING; CASE REPORT; CROSS RESISTANCE; DRUG EXPOSURE; EVOLUTION; GENOME; HUMAN; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

DIAGNOSTICS; GENOMICS; MRSA; SUB-POPULATIONS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EVOLUTION, MOLECULAR; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84892469777     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt354     Document Type: Article

References (16)

1. van Hal SJ, Jensen SO, Vaska VL et al. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 2012; 25: 362-86.
2. Liu C, Bayer A, Cosgrove SE et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52: e18-55.
3. Cameron DR, Ward DV, Kostoulias X et al. Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus. J Infect Dis 2012; 205: 1677-87.
4. Cui L, Isii T, Fukuda M et al. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrob Agents Chemother 2010; 54: 5222-33.
5. Howden BP, McEvoy CR, Allen DL et al. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulatorWalKR. PLoS Pathog 2011; 7: e1002359.
6. Mwangi MM, Wu SW, Zhou Y et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci USA 2007; 104: 9451-6.
7. Peleg AY, Miyakis S, Ward DV et al. Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus. PLoS One 2012; 7: e28316.
8. van Hal SJ, Paterson DL, Gosbell IB. Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naive patient-a review of the literature. Eur J Clin Microbiol Infect Dis 2011; 30: 603-10.
9. Young BC, Golubchik T, Batty EM et al. Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc Natl Acad Sci USA 2012; 109: 4550-5.
10. Harris SR, Cartwright EJ, Torok ME et al. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study. Lancet Infect Dis 2013; 13: 130-6.
11. Golubchik T, Batty EM, Miller RR et al. Within-host evolution of Staphylococcus aureus during asymptomatic carriage. PLoS One 2013; 8:e61319.
12. Gardete S, Kim C, Hartmann BM et al. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. PLoS Pathog 2012; 8: e1002505.
13. Steiner HY, Naider F, Becker JM. The PTR family: a new group of peptide transporters. Mol Microbiol 1995; 16: 825-34.
14. Gentry DR, Rittenhouse SF, McCloskey L et al. Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin. Antimicrob Agents Chemother 2007; 51: 2048-52.
15. Locke JB, Hilgers M, Shaw KJ. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother 2009; 53: 5265-74.
16. LaMarre JM, Howden BP, Mankin AS. Inactivation of the indigenous methyltransferase RlmN in Staphylococcus aureus increases linezolid resistance. Antimicrob Agents Chemother 2011; 55: 2989-91.